HTE established a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti cancer chemotherapy drugs in ready to administer presentations and agreed dose bands. The framework agreement covers the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses are based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.